Rosenberg Anthony 4
4 · Cullinan Therapeutics, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Rosenberg Anthony
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-12+38,513→ 38,513 totalExercise: $8.95Exp: 2035-06-12→ Common Stock (38,513 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date